Inflammation, Lifestyle and Chronic Diseases
254,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
127 °P sammeln
  • Gebundenes Buch

As a discussion on the role of inflammation in chronic disease and the effect on lifestyle, this text looks at cancer, autoimmune diseases, neurological diseases, pulmonary diseases, gastrointestinal diseases, metabolic diseases, and cardiovascular diseases. It examines the links between the diseases and risk factors such as chronic infections, obesity, alcohol, tobacco, radiation, environmental pollutants, and high-calorie diets. It covers anti-inflammatory agents made by man and Mother Nature as potential therapeutics to the symptoms and presents research on how the suppression of…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
As a discussion on the role of inflammation in chronic disease and the effect on lifestyle, this text looks at cancer, autoimmune diseases, neurological diseases, pulmonary diseases, gastrointestinal diseases, metabolic diseases, and cardiovascular diseases. It examines the links between the diseases and risk factors such as chronic infections, obesity, alcohol, tobacco, radiation, environmental pollutants, and high-calorie diets. It covers anti-inflammatory agents made by man and Mother Nature as potential therapeutics to the symptoms and presents research on how the suppression of proinflammatory pathways may provide opportunities for both prevention and treatment of chronic diseases.
Discussing the role of dysregulated inflammation and lifestyle in chronic diseases, this book looks at the link between inflammation and a range of disorders such as neurodegenerative, pulmonary, rheumatic, arthritic, gastrointestinal, skin, heart, and infectious diseases; asthma; insulin resistance; cancer; neuropsychiatric disorders; and chronic wounds. For each ailment, contributors review the clinical and scientific literature, examine current and potential therapies, and suggest directions for future research. Exploring how the suppression of pro-inflammatory pathways may provide opportunities for prevention and treatment, the book examines conventional pharmacotherapies such as steroids and NSAIDs alongside anti-inflammatory dietary agents.
Autorenporträt
Dr. Bharat Bhushan Aggarwal is the Ransom Home, Jr., Distinguished Professor of Cancer Research at the University of Texas MD Anderson Cancer Center Division of Cancer Medicine's Department of Experimental Therapeutics, and chief of the Cytokine Research Laboratory, in Houston, Texas. He earned a PhD in biochemistry at the University of California in Berkeley, then underwent postdoctoral training at the University of California Medical Center in San Francisco. He worked for ten years at Genentech, Inc., where he isolated and determined the structure of TNF-¿ and TNF-ß, before returning to a university-based academic position. Dr. Sunil Krishnan is director of Gastrointestinal Translational Research and associate professor of radiation oncology at the University of Texas MD Anderson Cancer Center in Houston, Texas. He received his MD degree at the Christian Medical College in Vellore, India, and then completed an internal medicine residency at Penn State Geisinger Medical Center in Danville, Pennsylvania, and a radiation oncology residency at Mayo Clinic College of Medicine in Rochester, Minnesota, before joining the University of Texas MD Anderson Cancer Center. Dr. Sushovan Guha is the site director of the Gastroenterology Fellowship Program and assistant professor of gastroenterology, hepatology, and nutrition at the University of Texas MD Anderson Cancer Center in Houston. He earned his MD degree from Jawaharlal Institute of Post-Graduate Medical Education and Research (JIPMER), Pondicherry, India, and graduated with an MA/MPhil in microbiology and immunology from Columbia University, New York. He completed his internship and residency in internal medicine at the Albert Einstein College of Medicine in the Bronx, New York. Dr. Guha then joined the prestigious Specialty Training and Advanced Research (STAR) Fellowship in Gastroenterology and Hepatology at the David Geffen School of Medicine at UCLA, Los Angeles, where he also received his PhD from the Molecular Biology Institute (MBI) under the astute tutelage of Professor Enrique Rozengurt.